Abstract
Purpose. To develop an intravenous injectable carrier composed of chitosan derivatives for taxol.
Methods. A chitosan with lauryl groups attached to amino groups to provide the hydrophobic moieties and, carboxymethyl groups attached to hydroxy groups to provide the hydrophilic moieties (N-lauryl-carboxymethyl-chitosan = LCC), was newly synthesized. The solubility of taxol in LCC micelles in aqueous solution was examined. The hemolysis test of LCC and the growth inhibition experiment of taxol-loading micelle using KB cells were also performed as in vitro assay.
Results. It was found that LCC solubilized taxol by forming micelles with particle sizes less than l00nm. This particle size was considered effective for passive targeting for tumors. The concentration of taxol in the micellar solution was very high, with a maximum of 2.37mg/ mL. This maximum was 1000 times above that in a saturated solution of taxol at pH 7.4. Hemolysis testing as an in vitro assay indicated that LCC was safer than Polysorbate 80 (TO-10M) as intravenous surfactant in terms of induction of membrane damage. As judged by cytostatic activity against KB cells, taxol retained activity even when included in LCC micelles. LCC-entrapped taxol was more effective in cytostatic activity than free taxol in low concentrations.
Conclusions. The results of solubilization capacity examination, hemolysis testing, and cytostatic activity suggest that LCC may be useful as a carrier of taxol.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
W. N. Waugh, L. A. Trissel, and V. J. Stella. Stability, compatibility and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. Am. J. Host. Pharm. 48:1520–1524 (1991).
N. Onetto, R. Canett, B. Winograd, R. Catane, M. Dougan, J. Grechko, J. Burroughs, and M. Rozencweig. Overview of taxol safety. J. Natl. Cancer Inst. Monogr. 15:131–139 (1993).
C. M. Spencer and D. Faulds. Paclitaxel: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potencial in the treatment of cancer. Drugs 48:794–847 (1994).
R. B. Greenwald and R. G. L. Shorr. Taxol-based compositions with enhanced bioactivity. PCT, WO 94/20089, 1994.
B. D. Tarr, T. G. Sambandan, and S. H. Yalkowsky. A new parenteral emulsion for the administration of taxol. Pharm. Res. 4:162–165 (1987).
H. Alkan-Onyuksel, S. Ramakrishnan, H. B. Chai, and J. M. Pezzuto. A mixed micellar formation suitable for the parenteral administration of taxol. Pharm. Res. 11:206–212 (1994).
A. Sharma and R. M. Straubinger. Novel taxol formulations: Preparation and characterization of taxol-containing liposomes. Pharm. Res. 11:889–896 (1994).
S. K. Dordunoo and H. M. Burt. Solubility and stability of taxol: Effects of buffer and cyclodextrins. Int. J. Pharm. 133:191–201 (1996).
X. Zhang, J. K. Jackson, and H. M. Burt. Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int. J. Pharm. 132:195–206 (1996).
M. Yokoyama, M. Miyauchi, N. Yamada, T. Okano, Y. Sakurai, K. Kataoka, and S. Inoue. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly (aspartic acid) block copolymer. Cancer Res. 50:1693–1700 (1990).
K. Kataoka, G. S. Kwon, M. Yokoyama, T. Okano, and Y. Sakurai. Block copolymer micelles as vehicles for drug delivery. J. Control. Rel. 24:119–132 (1993).
H. Yoshioka, K. Nonaka, K. Fukuda, and S. Kazama. Chitosanderive polymer-surfactants and their micellar properties. Biosci. Biotech. Biochem. 59:1901–1904 (1995).
J. P. Zikakis (Ed.). Chitin, Chitosan, and Related Enzymes. Academic Press, Orlando, FL (1984).
S. Tokura, N. Nishi, A. Tsutsumi, and O. Somorin. Studies on chitin VIII. Some properties of water soluble chitin derivatives. Polymer J. 15:485–489 (1983).
K. Akiyoshi, S. Deguchi, N. Moriguchi, S. Yamaguchi, and J. Sunamoto. Self-aggregates of Hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles. Macromolecules. 26:3062–3068 (1993).
M. C. Alley, D. A. Scudiero, A. Monks, M. L. Hursey, M. J. Czerwinski, D. L. Fine B. J. Abbott, J. G. Mayo, R. H. Shoemaker, and M. R. Boyd. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48:589–601 (1988).
Y. Inoue, M. Kaneko, and S. Tokura. The viscosity relationship of water soluble carboxymethyl chitin. Rep. Progr. Polym. Phys. Jap. 25:759–760 (1982).
A. Sharma, N. L. Straubinger, and R. M. Straubinger. Modulation of human ovarian tumor cell sensitivity to N-(phosphonacetyl)-L-aspartate (PALA) by liposome drug carriers. Pharm. Res. 10:1434–1441 (1993).
Y. Takakura, T. Fujita, H. Furitsu, M. Nishikawa, H. Sezaki, and M. Hashida. Pharmacokinetics of succinylated proteins and dextran sulfate in mice: Implications for hepatic targeting of protein drugs by direct succiniylation via scavenger receptors. Int. J. Pharm. 105:19–29 (1994).
S. Yasukawa, H. Ohshima, N. Muramatsu, and T. Kondo. Electrostatic interaction of microcapsules with guinea-pig polymorphonuclear leucocytes. J. Microencapsulation. 7:179–184 (1990).
Y. Ishikawa, N. Muramatsu, H. Ohshima, and T. Kondo. Effect of particle size on phagocytosis of latex particles by guinea-pig polymorphonuclear leucocytes. J. Biomater. Sci. Polymer Edn. 2:53–60 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miwa, A., Ishibe, A., Nakano, M. et al. Development of Novel Chitosan Derivatives as Micellar Carriers of Taxol. Pharm Res 15, 1844–1850 (1998). https://doi.org/10.1023/A:1011901921995
Issue Date:
DOI: https://doi.org/10.1023/A:1011901921995